Olaparib manages to slow the progression of metastatic prostate cancer
Prostate cancer is the most common form of cancer in men. Each year more than 1.2 million cases are diagnosed worldwide, and the disease causes … Read more
Prostate cancer is the most common form of cancer in men. Each year more than 1.2 million cases are diagnosed worldwide, and the disease causes … Read more
The prostate tumor is the one with the highest incidence in the Spanish male population with more than 30,000 new patients per year. The main … Read more
Two studies have shown the efficacy of alternatives to first-line chemotherapy for some subgroups of patients with advanced non-small cell lung cancer (NSCLC). This has … Read more
Immunotherapy is proving to be one of the most promising fields in cancer treatment and offers continuous advances. In this sense, the Congress of the … Read more
The ‘VITamin D and OmegA-3 Trial’ (VITAL) trial has yielded some positive results indicating that both vitamin D and Omega-3 fatty acids could be promising … Read more
Older breast cancer patients who exercised before being diagnosed may have a lower risk of cardiovascular disease compared to those who had not, according to … Read more
Read in Spanish In Mexico, heart conditions, diabetesand malignant tumors are the three main causes of death for both women and men, according to INEGI. … Read more
Several medical societies have committed themselves, through a document, to ensure cardiovascular health after the return to work of cancer patients. The endorsed document includes … Read more
During the ESMO 2019 celebration, one of the novelties presented has been different abstracts that highlight the results of avelumab as monotherapy and in combination … Read more
Magazine Journal of Experimental and Clinical Cancer Researchhas reported A study with promising results in triple negative breast cancer, even in those tumors resistant to … Read more